CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-05-12 | VANLENT ANNE Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-05-12 | DOUGHERTY MICHAEL R Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-05-12 | Richard John P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-05-12 | COX GEOFFREY F Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2015-05-12 | Fox James Director | Grant or award | +7,500 | $2.20 | $17K | 7,500 |
| 2015-03-27 | PATTI JOSEPH M CEO | Purchase | +10,000 | $2.27 | $23K | 111,128 |
| 2015-03-27 | PATTI JOSEPH M CEO | Purchase | +10,000 | $2.30 | $23K | 121,128 |
| 2014-10-01 | Azzarello Peter Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +130,000 | $2.45 | $319K | 130,000 |
| 2014-10-01 | PATTI JOSEPH M CEO and President | Grant or award · Stock Option (right to buy) | +475,000 | $2.45 | $1.2M | 475,000 |
| 2014-10-01 | PLUMB RUSSELL H Vice Chairmen | Grant or award | +40,000 | $2.45 | $98K | 40,000 |
| 2014-06-30 | PATTI JOSEPH M EVP, Corporate Dev & Strategy | Purchase | +10,000 | $2.86 | $29K | 68,241 |
| 2014-06-27 | PATTI JOSEPH M EVP, Corporate Dev & Strategy | Purchase | +4,200 | $2.81 | $12K | 66,441 |
| 2014-06-27 | PATTI JOSEPH M EVP, Corporate Dev & Strategy | Purchase | +800 | $2.78 | $2K | 67,241 |
| 2014-06-11 | PLUMB RUSSELL H CEO & President | Purchase | +4,331 | $2.79 | $12K | 102,579 |
| 2014-06-11 | PLUMB RUSSELL H CEO & President | Purchase | +2,310 | $2.99 | $7K | 104,889 |
| 2014-06-11 | PLUMB RUSSELL H CEO & President | Purchase | +22,690 | $3.09 | $70K | 127,579 |
| 2014-06-11 | PATTI JOSEPH M EVP, Corporate Dev & Strategy | Purchase | +2,995 | $2.80 | $8K | 59,620 |
| 2014-06-11 | PATTI JOSEPH M EVP, Corporate Dev & Strategy | Purchase | +2,621 | $2.97 | $8K | 62,241 |
| 2014-06-10 | PLUMB RUSSELL H CEO & President | Purchase | +2,700 | $2.45 | $7K | 98,248 |
| 2014-06-10 | PATTI JOSEPH M EVP, Corporate Dev & Strategy | Purchase | +8,451 | $2.45 | $21K | 56,225 |
Page 24 of 42 · 830 trades